|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Escitalopram
gptkb:Love_in_the_Time_of_Lexapro
gptkb:escitalopram
|
|
gptkbp:approves
|
gptkb:2002
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Lexapro
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:class
|
gptkb:selective_serotonin_reuptake_inhibitor_(SSRI)
|
|
gptkbp:clinical_trial
|
Phase IV
|
|
gptkbp:contraindication
|
MAO inhibitors
hypersensitivity to escitalopram
|
|
gptkbp:dosage_form
|
gptkb:tablet
10 mg
oral solution
5 mg
20 mg
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:formulation
|
oral solution
film-coated tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lexapro
|
|
gptkbp:indication
|
anxiety disorders
social anxiety disorder
obsessive-compulsive disorder
panic disorder
|
|
gptkbp:ingredients
|
C20 H21 F N2 O
escitalopram oxalate
|
|
gptkbp:interacts_with
|
gptkb:beer
gptkb:warfarin
NSAI Ds
other SSR Is
|
|
gptkbp:is_atype_of
|
N06 A X16
|
|
gptkbp:is_available_on
|
generic escitalopram
|
|
gptkbp:is_used_for
|
generalized anxiety disorder
major depressive disorder
|
|
gptkbp:lifespan
|
27 to 32 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
Forest Laboratories
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:population
|
gptkb:Person
available online
adults
adolescents
|
|
gptkbp:previous_name
|
gptkb:escitalopram
|
|
gptkbp:requires
|
available online
|
|
gptkbp:side_effect
|
dizziness
nausea
insomnia
dry mouth
bleeding disorders
sexual dysfunction
QT prolongation
serotonin syndrome
hyponatremia
|
|
gptkbp:storage
|
room temperature
dry place
protected from light
|
|
gptkbp:symptoms
|
dizziness
nausea
sleep disturbances
irritability
|